Inhibitory effect of paeoniflorin on methylglyoxal-mediated oxidative stress in osteoblastic MC3T3-E1 cells

Phytomedicine

Volumn 21, Issue 10, 2014, Pages 1170-1177

  Choi, Eun Mi ^a   Suh, Kwang Sik ^b   Rhee, Sang Youl ^c   Kim, Young Seol ^c  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

Cytotoxicity; Methylglyoxal; Mitochondrial function; Osteoblasts; Paeoniflorin

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARDIOLIPIN; GLUTATHIONE; INTERLEUKIN 6; LACTOYLGLUTATHIONE LYASE; METHYLGLYOXAL; NITRIC OXIDE; NUCLEAR RESPIRATORY FACTOR 1; PAEONIFLORIN; PROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; GLUCOSIDE; INTERLEUKIN-6, MOUSE; TERPENE;

3T3 CELL LINE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOGENESIS; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; OSTEOBLAST;

ANIMALS; CARDIOLIPINS; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; GLUCOSIDES; GLUTATHIONE; INTERLEUKIN-6; LIPID PEROXIDATION; MICE; MITOCHONDRIA; MONOTERPENES; NITRIC OXIDE; OSTEOBLASTS; OXIDATIVE STRESS; PYRUVALDEHYDE; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905051386     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2014.05.008     Document Type: Article

References (50)

1. F. Addabbo, B. Ratliff, H.C. Park, M. Kuo, Z. Ungvari, A. Csiszar, B. Krasnikov, K. Sodhi, F. Zhang, A. Nasjletti, and M.S. Goligorsky The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach Am. J. Pathol. 174 2009 34 43
2. A.A. Akhand, K. Hossain, H. Mitsui, M. Kato, T. Miyata, R. Inagi, J. Du, K. Takeda, Y. Kawamoto, H. Suzuki, K. Kurokawa, and I. Nakashima Glyoxal and methylglyoxal trigger distinct signals for MAP family kinases and caspase activation in human endothelial cells Free Radic. Biol. Med. 31 2001 20 30
3. A.A. Akhand, M. Kato, H. Suzuki, W. Liu, J. Du, M. Hamaguchi, T. Miyata, K. Kurokawa, and I. Nakashima Carbonyl compounds crosslink cellular proteins and activate protein-tyrosine kinase p60c-Src J. Cell. Biochem. 72 1999 1 7
4. M.T. Barati, M.L. Merchant, A.B. Kain, A.W. Jevans, K.R. Mcleich, and J.B. Klein Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice Am. J. Physiol. Renal Physiol. 293 2007 F1158 F1165
5. W. Cao, W. Zhang, J. Liu, Y. Wang, X. Peng, D. Lu, R. Qi, Y. Wang, and H. Wang Paeoniflorin improves survival in LPS-challenged mice through the suppression of TNF-α and IL-1β release and augmentation of IL-10 production Int. Immunopharmacol. 11 2011 172 178
6. W.H. Chan, H.J. Wu, and N.H. Shiao Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2 J. Cell. Biochem. 100 2007 1056 1069
7. E.M. Choi, and Y.S. Lee Paeoniflorin isolated from Paeonia lactiflora attenuates osteoblast cytotoxicity induced by antimycin A Food Funct. 4 2013 1332 1338
8. A. Dhar, I. Dhar, B. Jiang, K.M. Desai, and L. Wu Chronic methylglyoxal infusion by minipump causes pancreatic β-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats Diabetes 60 2011 899 908
9. C. Feng, M. Liu, X.W. Shi, W. Yang, D.Z. Kong, K.F. Duan, and Q.A. Wang Pharmacokinetic properties of paeoniflorin, albiflorin and oxypaeoniflorin after oral gavage of extracts of Radix Paeoniae Rubra and Radix Paeoniae Alba in rats J. Ethnopharmacol. 130 2010 407 413
10. R.B. Goldberg Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications J. Clin. Endocrinol. Metab. 94 2009 3171 3182
11. A. Goldin, J. Beckman, A. Schmidt, and M. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605
12. W.L. Jiang, X.G. Chen, H.B. Zhu, Y.B. Gao, J.W. Tian, and F.H. Fu Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis Basic Clin. Pharmacol. Toxicol. 105 2009 64 71
13. W. Jakubowski, and G. Bartosz 2,7-Dichlorofluorescin oxidation and reactive oxygen species: what does it measure? Cell Biol. Int. 24 2000 757 760
14. M.J. Kayath, E.F. Tavares, S.A. Dib, and J.G. Vieira Prospective bone mineral density evaluation in patients with insulin-dependent diabetes mellitus J. Diabet. Complicat. 12 1998 133 139
15. D.P. Kelly, and R.C. Scarpulla Transcriptional regulatory circuits controlling mitochondrial biogenesis and function Genes Dev. 18 2004 357 368
16. B. Lee, Y.W. Shin, E.A. Bae, S.J. Han, J.S. Kim, S.S. Kang, and D.H. Kim Antiallergic effect of the root of Paeonia lactiflora and its constituents paeoniflorin and paeonol Arch. Pharmacal Res. 31 2008 445 450
17. Y.E. Liu, Q.Q. Feng, and X.M. Zhang Effects of paeoniflorin on hemodynamics and myocardial oxygen consumption in anesthetic dogs Chin. J. Pharm. Anal. 9 2007 1390 1394
18. 2+ antagonism Phytother. Res. 25 2011 681 685
19. P. Matafome, C. Sena, and R. Seiça Methylglyoxal, obesity, and diabetes Endocrine 43 2013 472 484
20. M. Morcos, X. Du, F. Pfisterer, H. Hutter, A.A. Sayed, P.J. Thornalley, N. Ahmed, J. Baynes, S. Thorpe, G. Kukudov, A. Schlotterer, F. Bozorgmehr, R.A. El Baki, D. Stern, F. Moehrlen, Y. Ibrahim, D. Oikonomou, A. Hamann, C. Becker, M. Zeier, V. Schwenger, N. Miftari, P. Humpert, H.P. Hammes, M. Buechler, A. Bierhaus, M. Brownlee, and P.P. Nawroth Glyoxalase-I prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans Aging Cell 7 2008 260 269
21. K.K. Nicodemus, and A.R. Folsom Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women Diabetes Care 24 2001 1192 1197
22. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagushi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino, and M. Brownlee Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
23. E. Nisoli, S. Falcone, C. Tonello, V. Cozzi, L. Palomba, M. Fiorani, A. Pisconti, S. Brunelli, A. Cardile, M. Francolini, O. Cantoni, M.O. Carruba, S. Moncada, and E. Clementi Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals Proc. Natl. Acad. Sci. U. S. A. 101 2004 16507 16512
24. E. Nisoli, E. Clementi, M.O. Carruba, and S. Moncada Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ. Res. 100 2007 795 806
25. E. Nisoli, C. Tonello, A. Cardile, V. Cozzi, R. Bracale, L. Tedesco, S. Falcone, A. Valerio, O. Cantoni, E. Clementi, S. Moncada, and M.O. Carruba Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS Science 310 2005 314 317
26. I.T. Nizamutdinova, Y.C. Jin, J.S. Kim, M.H. Yean, S.S. Kang, Y.S. Kim, J.H. Lee, H.G. Seo, H.J. Kim, and K.C. Chang Paeonol and paeoniflorin, the main active principles of Paeonia albiflora, protect the heart from myocardial ischemia/reperfusion injury in rats Planta Med. 74 2008 14 18
27. C.H. Park, T. Tanaka, H.Y. Kim, J.C. Park, and T. Yokozawa Protective effects of Corni fructus against advanced glycation endproducts and radical scavenging eCAM 2012 1 7
28. M.G. Rosca, V.M. Monnier, L.I. Szweda, and M.F. Weiss Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal Am. J. Physiol. Renal Physiol. 283 2001 F52 F59
29. R.C. Scarpulla Transcriptional paradigms in mammalian mitochondrial biogenesis and function Physiol. Rev. 88 2008 611 638
30. E. Schulz, J. Dopheide, S. Schuhmacher, S.R. Thomas, K. Chen, A. Daiber, P. Wenzel, T. Munzel, and J.F. Keaney Jr. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction Circulation 118 2008 1347 1357
31. H. Sejersen, and S. Rattan Dicarbonyl-induced accelerated aging in vitro in human skin fibroblasts Biogerontology 10 2009 203 211
32. N. Shanmugam, Y.S. Kim, L. Lanting, and R. Natarajan Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products J. Biol. Chem. 278 2003 34834 34844
33. M.K. Shigenaga, T.M. Hagen, and B.M. Ames Oxidative damage and mitochondrial decay in aging Proc. Natl. Acad. Sci. U. S. A. 71 1994 10771 10778
34. A.W. Stitt, A.J. Jenkins, and M.E. Cooper Advanced glycation end products and diabetic complications Exp. Opin. Invest. Drugs 11 2002 1205 1223
35. T. Taguchi, M. Sugiura, Y. Hamada, and I. Miwa In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate Biochem. Pharmacol. 55 1998 1667 1671
36. P.J. Thornalley, and M.J. Tisdale Inhibition of proliferation of human promyelocytic leukaemia HL60 cells by S-d-lactoylglutathione in vitro Leuk. Res. 12 1988 897 904
37. P.J. Thornalley Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation Biochem. Soc. Trans. 31 2003 1343 1348
38. P.J. Thornalley Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification - a role in pathogenesis and antiproliferative chemotherapy Gen. Pharmacol. 27 1996 565 573
39. H. Wang, Q.H. Meng, T. Chang, and L. Wu Fructose-induced peroxynitrite production is mediated by methylglyoxal in vascular smooth muscle cells Life Sci. 79 2006 2448 2454
40. H. Wang, Q.H. Meng, J.R. Gordon, H. Khandwala, and L. Wu Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus Clin. Biochem. 40 2007 1232 1239
41. A.G. Welten, C.G. Schalkwijk, P.M. ter Wee, S. Meijer, J. van den Born, and R.J. Beelen Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response Perit. Dial. Int. 23 2003 213 221
42. H. Wu, W. Li, T. Wang, Y. Shu, and P. Liu Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells Biomed. Pharmacother. 62 2008 659 666
43. Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. Cinti, B. Lowell, R.C. Scarpulla, and B.M. Spiegelman Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 Cell 98 1999 115 124
44. C.H. Wu, S.M. Huang, and G.C. Yen Silymarin: a novel antioxidant with antiglycation and anti-inflammatory properties in vitro and in vivo Antioxid. Redox Signal. 14 2011 353 366
45. M. Xue, N. Rabbani, and P.J. Thornalley Glyoxalase in ageing Semin. Cell Dev. Biol. 22 2011 293 301
46. H.O. Yang, W.K. Ko, J.Y. Kim, and H.S. Ro Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora Fitoterapia 75 2004 45 49
47. D. Yao, T. Taguchi, T. Matsumura, R. Pestell, D. Edelstein, I. Giardino, G. Suske, N. Rabbani, P.J. Thornalley, V.P. Sarthy, H.P. Hammes, and M. Brownlee High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A J. Biol. Chem. 282 2007 31038 31045
48. P.H. Yen, P.V. Kiem, N.X. Nhiem, N.H. Tung, T.H. Quang, C.V. Minh, J.W. Kim, E.M. Choi, and Y.H. Kim A new monoterpene glycoside from the roots of Paeonia lactiflora increases the differentiation of osteoblastic MC3T3-E1 cells Arch. Pharmacal Res. 30 2007 1179 1185
49. H.S. Yim, S.O. Kang, Y.C. Hah, P.B. Chock, and M.B. Yim Free radicals generated during the glycation reaction of amino acids by methylglyoxal: a model study of protein-cross-linked free radicals J. Biol. Chem. 270 1995 28228 28233
50. X.J. Zhang, H.L. Chen, Z. Li, H.Q. Zhang, H.X. Xu, J.J. Sung, and Z.X. Bian Analgesic effect of paeoniflorin in rats with neonatal maternal separation-induced visceral hyperalgesia is mediated through adenosine A(1) receptor by inhibiting the extracellular signal-regulated protein kinase (ERK) pathway Pharmacol. Biochem. Behav. 94 2009 88 97